Cover Image
市場調查報告書

血管閉合設備的全球市場 (2016∼2020年)

Global Vascular Closure Devices Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 363479
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
血管閉合設備的全球市場 (2016∼2020年) Global Vascular Closure Devices Market 2016-2020
出版日期: 2016年07月13日 內容資訊: 英文 69 Pages
簡介

血管閉合設備市場以穩定性的速度也認為今後持續成長。全球各地心臟病患者持續增加事,及微創性的治療方法的需求高漲的事等,作為市場成長的主要原因能取得。另一方面,為了解除安全性等的問題巨額的研究開發 (R&D) 被實施,也有那個成為市場成長的妨礙的可能性。全球血管閉合設備市場2016∼2020年關於,8.67%的年複合成長率 (CAGR) 預計成長。

本報告提供全球血管閉合設備的市場相關分析,產品、技術概要和市場基本結構,市場規模趨勢 (今後5年的預測值),各產品、各用途、各終端用戶、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要
  • 心導管治療的大腿動脈進入
  • 心導管治療的橈骨動脈進入

第5章 比較分析的影響:手動壓縮設備、血管閉合設備

  • 臨床研究:血管閉合設備和手動壓縮設備比較分析

第6章 血管閉合設備的市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第7章 血管閉合設備的全球市場:各產品的市場區隔

  • 主動合攏器市場
  • 被動合攏器市場

第8章 血管閉合設備的全球市場:各用途的市場區隔

  • 診斷用介入
  • 治療用介入

第9章 血管閉合設備的全球市場:各終端用戶的市場區隔

  • 外科門診診療所 (ASC)
  • 醫院
  • 診療所

第10章 血管閉合設備的全球市場:地區區分

  • 南北美洲市場
  • 歐洲、中東、非洲各國 (EMEA) 市場
  • 亞太地區市場

第11章 血管閉合設備的全球市場:推動因素

  • 心臟病的發病率上升,和侵入性心導管治療的增加
  • 隨醫療影像技術的提高,低侵入性治療普及
  • 大腿動脈進入的心導管治療受歡迎

第12章 推動因素的影響力

第13章 血管閉合設備的全球市場:課題

  • 血管閉合設備的價格高,和醫療費償付方面的課題
  • 血管閉合設備的複雜性
  • 非侵入性CT血管造影術法

第14章 推動因素、課題的影響力

第15章 血管閉合設備的全球市場:趨勢

  • 經皮冠狀動脈介入治療 (PCI) 用機器人支援型導管治療受歡迎
  • 醫院用、數位式導管檢驗室的登場
  • 最新技術提高患者的舒適性

第16章 供應商環境

  • 競爭方案
  • 市場排行榜

第17章 主要供應商分析

  • Abbott Laboratories
  • Cardinal Health
  • St. Jude Medical
  • Vascular Solutions
  • 其他卓越供應商

第18章 附錄

  • 簡稱集

第19章 關於Technavio

目錄
Product Code: IRTNTR9652

About the Vascular Closure Devices Market

The global vascular closure devices market is likely to grow at a steady pace during the forecast period. This is because many clinical studies regarding vascular closure devices raised concerns about their safety and efficacy profiles. In many clinical cases, manual compressions were used as vascular closure devices that failed to show their efficacy. Vascular closure devices are used for both diagnostic and therapeutic interventions.

Concerns regarding these devices have led vendors to invest extensively in their R&D. These devices help in the diagnosis and treatment of cardiac diseases. A rise in the incidence of these diseases will lead to the demand and sales of vascular closure devices. The sales will further increase with the rapid adoption of minimally invasive equipment for cardiac surgeries. Minimally invasive surgeries such as angiography cause less pain, minimize infections, and help reduce hospital stay.

Technavio's analysts forecast the global vascular closure devices market to grow at a CAGR of 8.67% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global vascular closure devices market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of vascular closure devices used for arteriotomy site closure after cardiac catheterization.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Vascular Closure Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Cardinal Health
  • St. Jude Medical
  • Vascular Solutions

Other Prominent Vendors

  • Arstasis
  • Beijing Puyishengji Medical Technology
  • Endocor
  • Essential Medical
  • InSeal Medical
  • Medeon Biodesign
  • Morrris Innovative
  • Transluminal Technologies
  • Vascular Closure Systems
  • Vasorum
  • Vivasure Medical

Market driver

  • Minimally invasive procedures with improved medical imaging
  • For a full, detailed list, view our report

Market challenge

  • Complications of vascular closure devices
  • For a full, detailed list, view our report

Market trend

  • Popularity of robot-assisted catheterization for PCI
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Femoral artery access for cardiac catheterization
  • Radial artery access for cardiac catheterization

PART 05: Impact of comparative study on manual compression and vascular closure device

  • Clinical studies to compare vascular closure devices to manual compression devices

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product

  • Global vascular closure devices market for active approximators
  • Global vascular closure devices market for passive approximators

PART 08: Market segmentation by application

  • Diagnostic intervention
  • Therapeutic intervention

PART 09: Market segmentation by end-user

  • ASCs
  • Hospitals
  • Physicians' offices

PART 10: Geographical segmentation

  • Vascular closure devices market in Americas
  • Vascular closure devices market in EMEA
  • Vascular closure devices market in APAC

PART 11: Market drivers

  • Incidence of cardiac diseases and adoption of interventional cardiac catheterization
  • Minimally invasive procedures with improved medical imaging
  • Popularity of femoral arterial cardiac catheterization

PART 12: Impact of drivers

PART 13: Market challenges

  • High cost of vascular closure devices and reimbursement issues
  • Complications of vascular closure devices
  • Non-invasive CT angiography

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Popularity of robot-assisted catheterization for PCI
  • Emergence of digital cath labs in hospitals
  • Novel technologies to improve patient comfort

PART 16: Vendor landscape

  • Competitive scenario
  • Market ranking

PART 17: Major vendors

  • Abbott Laboratories
  • Cardinal Health
  • St. Jude Medical
  • Vascular Solutions
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Clinical trials on vascular closure devices compared with manual compression devices
  • Exhibit 03: Global vascular closure devices market segmentation
  • Exhibit 04: Global vascular closure devices market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global vascular closure devices market segmentation by product 2015
  • Exhibit 07: Global vascular closure devices market segmentation by product 2020
  • Exhibit 08: Different types of vascular closure devices for clinical practices
  • Exhibit 09: Global vascular closure devices market for active approximators 2015-2020 ($ billions)
  • Exhibit 10: Global vascular closure devices market for passive approximators 2015-2020 ($ millions)
  • Exhibit 11: Trends in diagnostic intervention
  • Exhibit 12: Trends in therapeutic intervention
  • Exhibit 13: Global vascular closure devices market segmentation by end-user 2015
  • Exhibit 14: Global vascular closure devices market segmentation by geography 2015
  • Exhibit 15: Global vascular closure devices market segmentation by geography 2020
  • Exhibit 16: Global vascular closure devices market segmentation by geography 2015-2020
  • Exhibit 17: Global vascular closure devices market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 18: Vascular closure devices market in Americas 2015-2020 ($ millions)
  • Exhibit 19: Comparison of US healthcare system: Before and after reforms
  • Exhibit 20: Implements amended in ACA
  • Exhibit 21: Number of coronary revascularization procedures per 100,000 people in EMEA 2013
  • Exhibit 22: Number of coronary angiography procedures in few countries in EMEA 2006 and 2013
  • Exhibit 23: Vascular closure devices market in EMEA 2015-2020 ($ millions)
  • Exhibit 24: Vascular closure devices market in APAC 2015-2020 ($ millions)
  • Exhibit 25: China: GDP 2010-2014 ($ trillions)
  • Exhibit 26: China: Healthcare expenditure 2009-2013 (% of GDP)
  • Exhibit 27: Impact of drivers
  • Exhibit 28: Impact of drivers and challenges
  • Exhibit 29: Global vascular closure devices market: Competitive landscape 2015
  • Exhibit 30: Ranking of vendors that develop active approximators 2015
  • Exhibit 31: Ranking of vendors that develop passive approximators 2015
  • Exhibit 32: Abbott Laboratories: Metrics analysis
  • Exhibit 33: Cardinal Health: Metrics analysis
  • Exhibit 34: St. Jude Medical: Metrics analysis
  • Exhibit 35: Vascular Solutions: Metrics analysis
  • Exhibit 36: Other prominent vendors
Back to Top